Perspective Therapeutics clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   MC1R-targeted Alpha-particle Monotherapy and Combination Therapy…MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab · Advanced Melanoma

   Trial sites expanded: 13 → 16 locations

   Perspective Therapeutics·Phase 1/2· NCT05655312· Registry history of NCT05655312 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

2. Minor

   Lead-212 PSV359 Therapy · Solid Tumors

   Trial sites expanded: 11 → 16 locations

   Perspective Therapeutics·Phase 1/2· NCT06710756· Registry history of NCT06710756 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.